Century Therapeutics grants 148K options to director
Century Therapeutics director Joseph Truitt received 148,000 stock options vesting over three years.
Rhea-AI Filing Summary
Century Therapeutics, Inc. (symbol: IPSC) is the issuer of record for a Form 4 filing submitted to the SEC. Truitt Joseph reported acquisition or exercise transactions in this Form 4 filing.
Century Therapeutics, Inc. (IPSC) reported that director Joseph Truitt received a grant of 148,000 stock options on September 9, 2026, each exercisable for one share of common stock at $2.03 per share and expiring on September 9, 2036. The options vest in equal monthly installments over 36 months, subject to his continued service to the company. Following this grant, he holds 148,000 options directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 148,000 shares
Grant/Award
1 txn
Insider
Truitt Joseph
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) F1 | 148,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 148,000 contracts (Direct)
Footnotes (1)
- F1. Century Therapeutics, Inc. (the "Company") issued to the Reporting Person stock options (the "Options") in connection with his appointment as a director. The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service to the Company and are issued pursuant to the Company's 2021 Equity Incentive Plan.
Key Figures
Stock options granted: 148,000 options
Exercise price: $2.03 per share
Expiration date: September 9, 2036
+2 more
5 metrics
Stock options granted
148,000 options
Grant to director Joseph Truitt on September 9, 2026
Exercise price
$2.03 per share
Exercise price for each option granted to Joseph Truitt
Expiration date
September 9, 2036
Expiration of options granted to Joseph Truitt
Vesting period
36 months
Options vest in equal monthly installments over 36 months
Options held after transaction
148,000 options
Total stock options held directly by Joseph Truitt after the grant
Key Terms
stock options, vest, Equity Incentive Plan, exercise price
4 terms
stock options financial
"issued to the Reporting Person stock options (the "Options") in connection with his appointment"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
vest financial
"The Options vest in equal monthly installments over 36 months subject to the Reporting Person's continued service"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
Equity Incentive Plan financial
"are issued pursuant to the Company's 2021 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
exercise price financial
"each exercisable for one share of common stock at $2.03 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Century Therapeutics (IPSC) report for director Joseph Truitt?
Century Therapeutics reported that director Joseph Truitt received a grant of 148,000 stock options on September 9, 2026, each for one share of common stock at an exercise price of $2.03 per share, expiring September 9, 2036.
What are the key terms of Joseph Truitt’s stock option grant at IPSC?
The grant consists of 148,000 stock options, each exercisable at $2.03 per share for Century Therapeutics common stock, with an expiration date of September 9, 2036. The options were issued in connection with his appointment as a director.
How do Joseph Truitt’s Century Therapeutics (IPSC) options vest?
The options granted to Joseph Truitt vest in equal monthly installments over 36 months, and vesting is subject to his continued service to Century Therapeutics during that period.
How many Century Therapeutics options does Joseph Truitt hold after this Form 4 transaction?
After this reported grant, Joseph Truitt holds 148,000 stock options for Century Therapeutics common stock, all held directly according to the filing.
Was Joseph Truitt’s IPSC option grant made under a Rule 10b5-1 trading plan?
No. The filing indicates that this stock option grant to Joseph Truitt is not reported as being made pursuant to a Rule 10b5-1 trading plan.
Under which plan were Joseph Truitt’s IPSC options issued?
Joseph Truitt’s options were issued under Century Therapeutics’ 2021 Equity Incentive Plan, in connection with his appointment as a director of the company.
AI-generated analysis. How Rhea-AI works. Not financial advice.
